Gov’t Doesn’t Appeal Favored-Nation Demo, But Suits May Still Weaken CMS’ Authority

By John Wilkerson / January 11, 2021 at 12:08 PM
The government is not appealing preliminary injunctions of the Trump administration’s most-favored-nation demonstration, but a separate industry lawsuit against the drug-pricing initiative is playing out in a way that could weaken or reinforce CMS’ power to run other nationwide, mandatory demos. The fate of the demo also could impact savings estimates of Democrats’ drug pricing legislation, which would affect the party’s ability to tackle drug pricing in budget reconciliation. “Per the Court’s Minute Order of December 31, 2020, Defendants hereby...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.